Fidelity International’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Fidelity International’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,429,038	Closed	-$148M	–	541
2015 Q3	$148M	Sell	3,429,038 -2,612,106	-43%	-$110M	0.52%	58
2015 Q2	$255M	Sell	6,041,144 -938,293	-13%	-$39.6M	0.81%	29
2015 Q1	$271M	Sell	6,979,437 -125,695	-2%	-$4.84M	0.87%	28
2014 Q4	$239M	Buy	7,105,132 +1,173,824	+20%	+$41.5M	0.83%	29
2014 Q3	$208M	Buy	5,931,308 +1,619,122	+38%	+$55.5M	0.8%	27
2014 Q2	$142M	Buy	4,312,186 +533,409	+14%	+$18.3M	0.53%	53
2014 Q1	$140M	Sell	3,778,777 -1,183,762	-24%	-$43.4M	0.51%	53
2013 Q4	$190M	Sell	4,962,539 -1,208,100	-20%	-$38.1M	0.77%	30
2013 Q3	$169M	Sell	6,170,639 -249,500	-4%	-$5.91M	0.81%	28
2013 Q2	$135M	Buy	+6,420,139	New	+$125M	0.76%	32

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Fidelity International's WX Position: Q4 2015 in Review

Fidelity International sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 3,429,038 shares — an estimated $148M sold.

Fidelity International first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $271M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Fidelity International reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Fidelity International sold 3,429,038 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $148M.
Fidelity International first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Fidelity International's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $271M in Q1 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Fidelity International's 13F filing for Q4 2015, filed 12 Feb 2016.